Patents by Inventor Jared HAMMILL

Jared HAMMILL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse
    Patent number: 12637410
    Abstract: The present invention relates to methods of treatment of a disease or pathology of the central nervous system, an eating disorder, or substance use disorder, drug dependence/abuse/addiction and withdrawal therefrom comprising administering at least one N-phenylalkyl amphetamine derivative and pharmaceutical compositions comprising at least one N-phenylalkyl amphetamine derivative to an individual in need thereof.
    Type: Grant
    Filed: June 16, 2022
    Date of Patent: May 26, 2026
    Assignee: University of Kentucky Research Foundation
    Inventors: Linda P. Dwoskin, David Watt, Jon Thorson, Mark Leggas, Rodney Kip Guy, Jared Hammill, Stefan Kwiatkowski, Derong Ding, Guangrong Zheng, Peter Anthony Crooks, Na-Ra Lee
  • Compositions and methods for treating malaria
    Patent number: 12370183
    Abstract: Disclosed are methods of treating malaria with tetrahydrobenzonaphtyridine carboxanilide (TBN) derivatives and related pyrrolinones and hydrolysis products thereof. These compounds are active against Plasmodium falciparum strains that are resistant to multiple drugs currently on the market. The present invention further relates to novel compounds and pharmaceutical compositions comprising such compounds.
    Type: Grant
    Filed: February 16, 2021
    Date of Patent: July 29, 2025
    Assignees: Rutgers, The State University of New Jersey, UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
    Inventors: Spencer Knapp, Robert D. Barrows, R. Kiplin Guy, Jared Hammill, Christopher Davis
  • Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse
    Patent number: 11999676
    Abstract: The present invention relates to methods of treatment of a disease or pathology of the central nervous system, an eating disorder, or substance use disorder, drug dependence/abuse and withdrawal therefrom comprising administering at least one N-phenylalkyl amphetamine derivative and pharmaceutical compositions comprising at least one N-phenylalkyl amphetamine derivative to an individual in need thereof.
    Type: Grant
    Filed: April 14, 2020
    Date of Patent: June 4, 2024
    Assignee: University of Kentucky Research Foundation
    Inventors: Linda P. Dwoskin, David Watt, Jon Thorson, Mark Leggas, Kip Guy, Jared Hammill, Stefan Kwiatkowski, Derong Ding, Guangrong Zheng, Peter Anthony Crooks, Na-Ra Lee
  • COMPOSITIONS AND METHODS FOR TREATING MALARIA
    Publication number: 20230139910
    Abstract: Disclosed are methods of treating malaria with tetrahydrobenzonaphtyridine carboxanilide (TBN) derivatives and related pyrrolinones and hydrolysis products thereof. These compounds are active against Plasmodium falciparum strains that are resistant to multiple drugs currently on the market. The present invention further relates to novel compounds and pharmaceutical compositions comprising such compounds.
    Type: Application
    Filed: February 16, 2021
    Publication date: May 4, 2023
    Inventors: Spencer Knapp, Robert D. Barrows, R. Kiplin Guy, Jared Hammill, Christopher Davis
  • Vesicular Monoamine Transporter-2 Ligands and Their Use in the Treatment of Psychostimulant Abuse
    Publication number: 20220315523
    Abstract: The present invention relates to methods of treatment of a disease or pathology of the central nervous system, an eating disorder, or substance use disorder, drug dependence/abuse/addiction and withdrawal therefrom comprising administering at least one N-phenylalkyl amphetamine derivative and pharmaceutical compositions comprising at least one N-phenylalkyl amphetamine derivative to an individual in need thereof.
    Type: Application
    Filed: June 16, 2022
    Publication date: October 6, 2022
    Inventors: Linda P. DWOSKIN, David WATT, Jon THORSON, Mark LEGGAS, Rodney Kip GUY, Jared HAMMILL, Stefan KWIATKOWSKI, Derong DING, Guangrong ZHENG, Peter Anthony CROOKS, Na-Ra LEE
  • Vesicular Monoamine Transporter-2 Ligands and Their Use in the Treatment of Psychostimulant Abuse
    Publication number: 20200290948
    Abstract: The present invention relates to methods of treatment of a disease or pathology of the central nervous system, an eating disorder, or substance use disorder, drug dependence/abuse and withdrawal therefrom comprising administering at least one N-phenylalkyl amphetamine derivative and pharmaceutical compositions comprising at least one N-phenylalkyl amphetamine derivative to an individual in need thereof.
    Type: Application
    Filed: April 14, 2020
    Publication date: September 17, 2020
    Inventors: Linda P. DWOSKIN, David WATT, Jon THORSON, Mark LEGGAS, Kip GUY, Jared HAMMILL, Stefan KWIATKOWSKI, Derong DING, Guangrong ZHENG, Peter Anthony CROOKS, Na-Ra LEE